“ASSESSMENT OF CARDIOVASCULAR AND RENAL OUTCOMES FOLLOWING DAPAGLIFLOZIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE” (2026) Asian Journal of Medical Research and Health Sciences, 4(2), pp. 1398–1403. Available at: https://www.ajmrhs.com/journal/article/view/617 (Accessed: 1 July 2026).